Publications

A NEW APPROACH OF PRECLINICAL TESTING OF CHEMOTHERAPIES – AN EXAMPLE OF BRAIN TUMOUR THERAPY

Authors: B Nimmervoll, Y Patel, B Bianski, M DeCuypere, A Shelat, C Stewart, T Merch...

E-pub date: 1 Jun 2016

Journal name: NEURO-ONCOLOGY

NEWLY DISCOVERED ONCOGENES DRIVING AND MAINTAINING CHOROID PLEXUS CARCINOMA PROVIDE POTENTIALLY DRUGGABLE TARGETS

Authors: Y Tong, D Merino, B Nimmervoll, K Gupta, D Finkelstein, DW Ellison, J Zang,...

E-pub date: 1 Jun 2016

Journal name: NEURO-ONCOLOGY

ACCURATE PRECLINICAL TRIALS OF NEW EPENDYMOMA THERAPIES

Authors: N Boulos, J Dapper, Y Patel, M DeCuypere, B Bianski, T Merchant, B Freeman,...

E-pub date: 1 Jun 2016

Journal name: NEURO-ONCOLOGY

MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

Authors: T Phoenix, D Patmore, S Boop, N Boulos, M Jacus, Y Patel, M Roussel, D Fink...

E-pub date: 1 Jun 2016

Journal name: NEURO-ONCOLOGY

LECTIN-BASED NEAR INFRA-RED MOLECULAR IMAGING FOR DYSPLASIA DETECTION IN BARRETT’S OESOPHAGUS: AN EX-VIVO STUDY ON HUMAN TISSUE

Authors: M Di Pietro, A Neves, M O'Donovan, D Waterhouse, S Bohndiek, K Brindle, RC ...

E-pub date: 1 Jun 2016

Journal name: Gut

A NOTCH1-DRIVEN SECRETOME SWITCH MODULATES IMMUNE SURVEILLANCE IN RAS-INDUCED SENESCENCE

Authors: M Hoare, Y Ito, T-W Kang, S Menon, R Salama, L Zender, M Narita

E-pub date: 1 Jun 2016

Journal name: Gut

Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.

Authors: CL Sutherell, C Tallant, OP Monteiro, C Yapp, JE Fuchs, O Fedorov, P Siejka...

E-pub date: 26 May 2016

Journal name: J Med Chem

CALIBRATE: Intensive profiling of circulating tumour DNA (ctDNA) from patients participating in experimental therapeutics trials including mutational profiles and copy number changes.

Authors: J Garcia-Corbacho, F Mouliere, H Carr, JA Morris, F Marrass, DG Gale, S Kum...

E-pub date: 20 May 2016

Journal name:

Filters

Research Groups

Core Facilities

Start date

End date

A NEW APPROACH OF PRECLINICAL TESTING OF CHEMOTHERAPIES – AN EXAMPLE OF BRAIN TUMOUR THERAPY

NEWLY DISCOVERED ONCOGENES DRIVING AND MAINTAINING CHOROID PLEXUS CARCINOMA PROVIDE POTENTIALLY DRUGGABLE TARGETS

ACCURATE PRECLINICAL TRIALS OF NEW EPENDYMOMA THERAPIES

MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

LECTIN-BASED NEAR INFRA-RED MOLECULAR IMAGING FOR DYSPLASIA DETECTION IN BARRETT’S OESOPHAGUS: AN EX-VIVO STUDY ON HUMAN TISSUE

A NOTCH1-DRIVEN SECRETOME SWITCH MODULATES IMMUNE SURVEILLANCE IN RAS-INDUCED SENESCENCE

Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.

CALIBRATE: Intensive profiling of circulating tumour DNA (ctDNA) from patients participating in experimental therapeutics trials including mutational profiles and copy number changes.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

A NEW APPROACH OF PRECLINICAL TESTING OF CHEMOTHERAPIES – AN EXAMPLE OF BRAIN TUMOUR THERAPY

NEWLY DISCOVERED ONCOGENES DRIVING AND MAINTAINING CHOROID PLEXUS CARCINOMA PROVIDE POTENTIALLY DRUGGABLE TARGETS

ACCURATE PRECLINICAL TRIALS OF NEW EPENDYMOMA THERAPIES

MEDULLOBLASTOMA GENOTYPE DICTATES BLOOD BRAIN BARRIER PHENOTYPE

LECTIN-BASED NEAR INFRA-RED MOLECULAR IMAGING FOR DYSPLASIA DETECTION IN BARRETT’S OESOPHAGUS: AN EX-VIVO STUDY ON HUMAN TISSUE

A NOTCH1-DRIVEN SECRETOME SWITCH MODULATES IMMUNE SURVEILLANCE IN RAS-INDUCED SENESCENCE

Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.

CALIBRATE: Intensive profiling of circulating tumour DNA (ctDNA) from patients participating in experimental therapeutics trials including mutational profiles and copy number changes.